Skip to content

NO Sensor to Record Wound Data in Acute or Chronic Wounds

A Single-Center Pilot Study to Test the Effectiveness of the REPAIR Nitric Oxide (NO) Sensor to Record Wound Characteristic Data

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06944899
Enrollment
10
Registered
2025-04-25
Start date
2025-05-20
Completion date
2025-10-28
Last updated
2025-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Volumetric Muscle Loss

Brief summary

The purpose of this research is to evaluate the ability of a Nitric Oxide (NO) Sensor to collect NO measurement data from an open wound. Previous research suggests that NO levels may indicate the stage of healing the wound is in. This study is being done to determine if the NO Sensor can measure how much NO is in a participant's wound. The researcher will place the NO Sensor into a participant's wound to collect NO measurements for 30-60 minutes. The participant will then have 2 follow-up appointments to see how the wound heals over time.

Interventions

DEVICENO Sensor

NO sensor measuring wound characteristic data in wound bed

Sponsors

Defense Advanced Research Projects Agency
CollaboratorFED
Stephen Badylak
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

proof of concept

Eligibility

Sex/Gender
ALL
Age
22 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Extremity injury 2. Wound surface area 2-10 cm in diameter 3. Wound amenable to NO Sensor placement 4. Age at the time of consent ≥ 22 to ≤ 65 years 5. Cognitively able to undergo informed consent discussion and understand the study

Exclusion criteria

1. Chemotherapy 2. Pregnancy 3. Preexisting immunosuppressive conditions or immunosuppression therapy 4. Active hemorrhage in the wound bed 5. Physician discretion for patients with complex medical conditions or high mortality risks 6. Patients with an active implanted device, such as a pacemaker, defibrillator, or hypoglossal or vagal nerve stimulator 7. Patients requiring a legally authorized representative (LAR) for informed consent

Design outcomes

Primary

MeasureTime frameDescription
Participants meet all inclusion/exclusion criteria - a minimum of 5 participants have completed Inclusion/Exclusion in CRF-01up to 8 weeks
All wound characteristics documented - a minimum of 5 wounds assessed by Bates-Jensen Wound Assessment Tool. And documented in CRF-03Day 0
NO Sensor application time > 30 minutes and < 60 minutes - a minimum of 5 wounds have NO sensor applied between 30-60 minutes and documented in CRF-0460 minutes
NO Sensor applied and removed according to study specific SOPs - a minimum of 5 wounds have NO Sensor applied and removed according to study specific SOPs and documented in CRF-04Day 0
Assessment of wound healing during participant follow-up activities - a minimum of 5 participants have follow up wound assessments according to visit schedule and documented in CRF-05 and CRF-06up to 8 weeksA follow up phone call within 72 hours and an in-person clinic visit within 2-8 weeks of NO Sensor application

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026